The development of highly effective interventions against malaria remains a research
priority. Individuals in endemic areas develop a non-sterilizing form of immunity, and …

Full article: Monoclonal antibodies for the prevention of Plasmodium falciparum malaria: a
multi-target approach? Skip to Main Content Taylor and Francis Online homepage Taylor and …

Malaria is a life-threatening infectious disease caused by Plasmodium species. There are
about 250 Plasmodium species discovered in the world. Amongst them, only five species …

Concerted efforts to fight malaria have caused significant reductions in global malaria cases
and mortality. Sustaining this will be critical to avoid rebound and outbreaks of seasonal …

Monoclonal antibodies are highly specific proteins that are cloned from a single B cell and
bind to a single epitope on a pathogen. These laboratory-made molecules can serve as …

Nacer A, Kivi G, Pert R, Juronen E, Holenya P, Aliprandini E, Amino R, Silvie O, Quinkert D,
Le Duff Y, Hurley M, Reimer U, Tover A, Draper SJ, Gilbert S, Ho MM and Bowyer PW (2022) …

1.1 PREVALENCE, SEVERITY AND IMPACT ON WORLD HEALTH Malaria is an important
cause of morbidity and mortality, particularly in sub-Saharan Africa where it accounts for …

Malaria is one of the most prevalent parasitic infections caused by Plasmodium spp.
threatening millions of people in tropical and subtropical countries. The disease affected 247 …

The observation that individuals living in malaria endemic regions who are repeatedly
infected with P. falciparum can acquire immunity, first to severe, then to uncomplicated …

Malaria remains a major global health challenge, causing over 0.6 million yearly deaths. To
understand naturally acquired immunity in adult human populations in malaria-prevalent …